Literature DB >> 30196105

Familial risk of pleural mesothelioma increased drastically in certain occupations: A nationwide prospective cohort study.

Elham Kharazmi1, Tianhui Chen2, Mahdi Fallah3, Kristina Sundquist4, Jan Sundquist4, Maria Albin5, Elisabete Weiderpass6, Kari Hemminki7.   

Abstract

OBJECTIVE: We aimed to explore the effect of occupation on familial risk of pleural mesothelioma in a nationwide cohort study design.
METHOD: The nationwide Swedish Family-Cancer Database includes all Swedes born after 1931 and their biological parents, totalling 16.1 million individuals with about 2.3 million cancer patients. Hazards ratios (HRs) were calculated adjusting for age, sex and region of residence.
RESULTS: Having asbestos-related occupation in the absence of family history of mesothelioma increased risk of mesothelioma more than threefold (adjusted HR = 3.2, 95% confidence interval [CI]: 3.0-3.5). In those who had a history of mesothelioma in their first-degree relatives and an asbestos-related occupation, risk of mesothelioma dramatically increased compared with individuals without such occupations and family history (without chronic obstructive pulmonary disease [COPD] HR = 24, 95% CI: 15-39; with COPD 45, 95% CI: 15-141). In those who had a family history of mesothelioma and no history of an asbestos-related occupation, risk of mesothelioma did not show significant increase compared with those who had no family history of mesothelioma and no asbestos-related occupation (HR = 1.6; 95% CI: 0.7-3.8).
CONCLUSION: First-degree relatives of patients with pleural mesothelioma had a drastic risk of developing this malignancy in case of certain occupations, which shows a gene-environment interaction is probable in risk of mesothelioma.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Familial risk; First-degree relatives; Mesothelioma; Occupation

Mesh:

Year:  2018        PMID: 30196105     DOI: 10.1016/j.ejca.2018.07.139

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.

Authors:  Raffit Hassan; Betsy Morrow; Anish Thomas; Tom Walsh; Ming K Lee; Suleyman Gulsuner; Meghana Gadiraju; Vasiliki Panou; Shaojian Gao; Idrees Mian; Javed Khan; Mark Raffeld; Snehal Patel; Liqiang Xi; Jun S Wei; Mary Hesdorffer; Jingli Zhang; Kathleen Calzone; Arpita Desai; Emerson Padiernos; Christine Alewine; David S Schrump; Seth M Steinberg; Hedy L Kindler; Mary-Claire King; Jane E Churpek
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

2.  Pleural plaques by inhalation of asbestos fibers.

Authors:  Diemen Delgado; Oscar Ramírez; Nayab Sultan; Patricio Miranda; Ashley Delgado
Journal:  Rev Bras Med Trab       Date:  2020-12-11

3.  Distribution of Asbestos Enterprises and Asbestosis Cases - China, 1997-2019.

Authors:  Mingfeng Chen; Huanqiang Wang; Jianfang Zhang; Chen Yu; Weidong Liu; Yunhao Xu
Journal:  China CDC Wkly       Date:  2020-05-01

4.  Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.

Authors:  Kari Hemminki; Asta Försti; Tianhui Chen; Akseli Hemminki
Journal:  BMC Cancer       Date:  2021-11-08       Impact factor: 4.430

5.  Assessment of Global Trends in the Diagnosis of Mesothelioma From 1990 to 2017.

Authors:  Zhen Zhai; Jian Ruan; Yi Zheng; Dong Xiang; Na Li; Jingjing Hu; Jianfei Shen; Yujiao Deng; Jia Yao; Peng Zhao; Shuqian Wang; Si Yang; Linghui Zhou; Ying Wu; Peng Xu; Lijuan Lyu; Jun Lyu; Raymond Bergan; Tianhui Chen; Zhijun Dai
Journal:  JAMA Netw Open       Date:  2021-08-02

6.  Advancing precision public health using human genomics: examples from the field and future research opportunities.

Authors:  Megan C Roberts; Alison E Fohner; Latrice Landry; Dana Lee Olstad; Amelia K Smit; Erin Turbitt; Caitlin G Allen
Journal:  Genome Med       Date:  2021-06-01       Impact factor: 11.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.